Hikma CEO Riad Mishlawi expressed confidence in the company's outlook, saying: "It's been another strong year for Hikma with double-digit revenue growth, increased profits and a resilient margin." ...

Thank you for joining our 2024 full year results presentation. I am Riad Mishlawi, CEO of Hikma, and I am joined here with Khalid Nabilsi, our CFO. I will kick off by providing a quick summary of ...

Darwazah has been with Hikma Pharmaceuticals for 42 years. He has been the CEO since 2007 and was appointed executive chairman in 2014. The company is listed on the London Stock Exchange and is the ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Drugmaker Hikma is in talks with partners across the world to prepare to sell a generic version of Ozempic ...

The company reported increased market share in sodium oxybate and strong performance from its nasal spray franchise. Hikma CEO Riad Mishlawi expressed confidence in the company's outlook, saying: ...